You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Von Willebrand Factor antibody (FITC) (ab8822)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Von Willebrand Factor antibody (FITC)
See all Von Willebrand Factor products (23) ...

Description

Sheep polyclonal to Von Willebrand Factor (FITC)

Conjugation

FITC

Conjugation notes

Fluorescein Isothiocyante (FITC)

Specificity

The unconjugated immunoglobulin gives no arcs when tested by immunoelectrophoresis against human serum. Identity has been confirmed by double diffusion (Ouchterlony) against von Willebrand Factor and an anti-von Willebrand Factor of known specificity.

Tested applications

IHC-Fr, ICC/IF, Flow Cytmore details

Cross reactivity

Reacts with

Rat, Human

Immunogen

Human Von Willebrand Factor Antigen prepared from citrated human plasma. Greater than 95% purity by SDS-PAGE.

Positive control

Direct on frozen sections of human tonsil.

Properties

Form

Liquid

Storage instructions

Store at +4°C.

Storage buffer

PBS, pH 7.2, sodium azide, 0.1%

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Myeloma

unknown

Isotype

IgG

Light chain type

unknown

Applications

Show applications key

Our Abpromise guarantee covers the use of ab8822 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • IHC-Fr

     IHC-Fr: 1/50 - 1/100.

    IHC-Fr: 1/50 - 1/100.

  • ShowHide

    ICC/IF

     ICC/IF: Use at an assay ...Read more →

    ICC/IF: Use at an assay dependent dilution. (PubMed: 20448112)

  • ShowHide

    Flow Cyt

     Flow Cyt: Use at an assa...Read more →

    Flow Cyt: Use at an assay dependent concentration. (PubMed: 21050042)

Target

Function

Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma.

Tissue specificity

Plasma.

Involvement in disease

Defects in VWF are the cause of von Willebrand disease (VWD) [MIM:277480]. VWD defines a group of hemorrhagic disorders in which the von Willebrand factor is either quantitatively or qualitatively abnormal resulting in altered platelet function. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII and impaired platelet adhesion. Type I von Willebrand disease is the most common form and is characterized by partial quantitative plasmatic deficiency of an otherwise structurally and functionally normal Willebrand factor; type II is associated with a qualitative deficiency and functional anomalies of the Willebrand factor; type III is the most severe form and is characterized by total or near-total absence of Willebrand factor in the plasma and cellular compartments, also leading to a profound deficiency of plasmatic factor VIII.

Sequence similarities

Contains 1 CTCK (C-terminal cystine knot-like) domain.
Contains 4 TIL (trypsin inhibitory-like) domains.
Contains 3 VWFA domains.
Contains 3 VWFC domains.
Contains 4 VWFD domains.

Domain

The von Willebrand antigen 2 is required for multimerization of vWF and for its targeting to storage granules.

Post-translational
modifications

All cysteine residues are involved in intrachain or interchain disulfide bonds.
N- and O-glycosylated.

Cellular localization

Secreted. Secreted > extracellular space > extracellular matrix. Localized to storage granules.

Target information above from: UniProt accessionP04275 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Coagulation factor VIII antibody
  • F8VWF antibody
  • Factor VIII related antigen antibody
  • von Willebrand antigen 2 antibody
  • Von Willebrand antigen II antibody
  • Von Willebrand disease antibody
  • VWD antibody
  • VWF antibody
  • VWF_HUMAN antibody
see all

References for Anti-Von Willebrand Factor antibody (FITC) (ab8822)

This product has been referenced in:

  • Valentijn KMet al. Multigranular exocytosis of Weibel-Palade bodies in vascular endothelial cells. Blood 116:1807-16 (2010). ICC/IF; Human.Read more (PubMed: 20448112) »
  • Cui Let al. New monoclonal antibody B7 selectively recognizes rat myocardium microvascular endothelial cells. Hybridoma (Larchmt) 29:413-8 (2010). Flow Cyt; Rat.Read more (PubMed: 21050042) »

See all 3 publications for this product

Publishing research using ab8822? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"